Therapeutic potential of endothelin receptor antagonists in diabetes

被引：11

作者：

Chakrabarti, S ^{[1
]}

Cukiernik, M ^{[1
]}

Mukherjee, S ^{[1
]}

Chen, SL ^{[1
]}

机构：

[1] Univ Western Ontario, Dept Pathol, London, ON, Canada

来源：

EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2000年 / 9卷 / 12期

关键词：

cardiomyopathy; diabetic complications; endothelins; endothelin antagonism; nephropathy; neuropathy; retinopathy;

D O I：

10.1517/13543784.9.12.2873

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Endothelins (ETs) are widely distributed in the body and perform several vascular and non-vascular functions. Experimental evidence indicates that abnormalities of the ET system occur in several organs affected in chronic diabetic complications. Furthermore, ET antagonists were found to prevent structural and functional changes in the target organs of chronic diabetic complications in animal models. Abnormalities of plasma ET levels have also been demonstrated in human diabetes. This review discusses the role of ET in the pathogenesis of chronic diabetic complications. The current experimental evidence suggests that ET antagonism may potentially represent an adjuvant therapeutic tool in the treatment of chronic diabetic complications.

引用

页码：2873 / 2888

页数：16

共 167 条

[1] Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor
Aiello, LP
Bursell, SE
Clermont, A
Duh, E
Ishii, H
Takagi, C
Mori, F
Ciulla, TA
Ways, K
Jirousek, M
Smith, LEH
King, GL
[J]. DIABETES, 1997, 46 (09) : 1473 - 1480
[2] Discovery and synthesis of (S)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-2-(4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic acid (LU 302872), a novel orally active mixed ETA/ETB receptor antagonist
Amberg, W
Hergenröder, S
Hillen, H
Jansen, R
Kettschau, G
Kling, A
Klinge, D
Raschack, R
Riechers, H
Unger, L
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (16) : 3026 - 3032
[3] ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
[4] ARAI K, 1987, J BIOL CHEM, V262, P16969
[5] AWANE Y, 1994, JPN J PHARM S1, V64, pAO337
[6] COMPARISON OF PD-145065 AND RO 46-2005 AS ANTAGONISTS OF CONTRACTIONS OF GUINEA-PIG AIRWAYS INDUCED BY ENDOTHELIN-1 OR IRL-1620
BATTISTINI, B
WARNER, TD
FOURNIER, A
VANE, JR
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 252 (03) : 341 - 345
[7] BECK GR, 1995, J CARDIOVASC PHARM, V26, pS385
[8] Endothelin antagonists and renal protection
Benigni, A
Perico, N
Remuzzi, G
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 : S75 - S78
[9] Blakesley Vicky A., 1996, P824
[10] Blom M L, 1994, Del Med J, V66, P379

← 1 2 3 4 5 6 7 8 9 10 →